Bio Rad Laboratories Inc
Change company Symbol lookup
Select an option...
BIO Bio Rad Laboratories Inc
VTNR Vertex Energy Inc
BFI Burgerfi International Inc
ATRO Astronics Corp
BHR Braemar Hotels & Resorts Inc
NBSTU Newbury Street Acquisition Corp
SKX Skechers USA Inc
IGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025
NHIC Newhold Investment II Corp
MMI Marcus & Millichap Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Growth
Company profile

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. Its segments include Life Science and Clinical Diagnostics. Its Life Science segment markets and develops, manufactures and markets approximately 9,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Its Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. It supplies approximately 3,000 different products that cover over 300 clinical diagnostic tests to the in vitro diagnostics (IVD) test market.

Closing Price
$495.16
Day's Change
-12.53 (-2.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
513.45
Day's Low
495.05
Volume
(Average)
Volume:
173,156

10-day average volume:
176,998
173,156

Upcoming Events

BIO's fiscal year ends in December
There are no upcoming events for BIO

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
April 28, 2022Q1 2022 Earnings Release$4.94$2.80 to $3.98$5.21
February 10, 2022Q4 2021 Earnings Release$3.21$2.79 to $2.93$4.01
October 28, 2021Q3 2021 Earnings Release$3.71$2.30 to $2.82$3.00
July 29, 2021Q2 2021 Earnings Release$3.54$1.90 to $3.19$1.61

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.